Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernhard Kratzer

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
International Archives of Allergy and Immunology|March 9, 2016
Years in Review: Recent Progress in Cellular AllergologyBernhard Kratzer, Winfried F Pickl
International Archives of Allergy and Immunology|September 20, 2016
On Peptides and Altered Peptide Ligands: From Origin, Mode of Action and Design to Clinical Application (Immunotherapy)Martín Candia, Bernhard Kratzer, Winfried F Pickl
European Journal of Immunology|April 5, 2020
Soluble pattern recognition molecules: Guardians and regulators of homeostasis at airway mucosal surfacesUrsula Smole, Bernhard Kratzer, Winfried F Pickl
European Journal of Immunology|December 5, 2019
All the small things: How virus-like particles and liposomes modulate allergic immune responsesBernhard Kratzer, Sandra Hofer, Maja Zabel, et al.
Allergy|January 29, 2020
Allergen alters IL-2/αIL-2-based Treg expansion but not tolerance induction in an allergen-specific mouse modelCordula Köhler, Ursula Smole, Bernhard Kratzer, et al.
International Archives of Allergy and Immunology|December 12, 2023
The T-Cell Growth Factor Interleukin-2, Which Is Occasionally Targeted by Autoantibodies, Qualifies as Drug for the Treatment of Allergy, Autoimmunity, and Cancer: Collegium Internationale Allergologicum (CIA) Update 2024Al Nasar Ahmed Sehgal, Peter A Tauber, Robert B Stieger, et al.
Vaccines|July 27, 2024
Macropinocytosis Is the Principal Uptake Mechanism of Antigen-Presenting Cells for Allergen-Specific Virus-like NanoparticlesArmin Kraus, Bernhard Kratzer, Al Nasar Ahmed Sehgal, et al.
Applied Microbiology and Biotechnology|August 28, 2014
Accurate comparison of antibody expression levels by reproducible transgene targeting in engineered recombination-competent CHO cellsPatrick Mayrhofer, Bernhard Kratzer, Wolfgang Sommeregger, et al.
International Journal of Molecular Sciences|July 12, 2025
Moloney Murine Leukemia Virus-like Nanoparticles Pseudo-Typed with SARS-CoV-2 RBD for Vaccination Against COVID-19Bernhard Kratzer, Pia Gattinger, Peter A Tauber, et al.
Frontiers in Immunology|August 1, 2020
Preventive Allergen-Specific Vaccination Against Allergy: Mission Possible?Inna Tulaeva, Bernhard Kratzer, Raffaela Campana, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
International Archives of Allergy and Immunology|March 9, 2016
Years in Review: Recent Progress in Cellular AllergologyBernhard Kratzer, Winfried F Pickl
International Archives of Allergy and Immunology|September 20, 2016
On Peptides and Altered Peptide Ligands: From Origin, Mode of Action and Design to Clinical Application (Immunotherapy)Martín Candia, Bernhard Kratzer, Winfried F Pickl
European Journal of Immunology|April 5, 2020
Soluble pattern recognition molecules: Guardians and regulators of homeostasis at airway mucosal surfacesUrsula Smole, Bernhard Kratzer, Winfried F Pickl
European Journal of Immunology|December 5, 2019
All the small things: How virus-like particles and liposomes modulate allergic immune responsesBernhard Kratzer, Sandra Hofer, Maja Zabel, et al.
Allergy|January 29, 2020
Allergen alters IL-2/αIL-2-based Treg expansion but not tolerance induction in an allergen-specific mouse modelCordula Köhler, Ursula Smole, Bernhard Kratzer, et al.
International Archives of Allergy and Immunology|December 12, 2023
The T-Cell Growth Factor Interleukin-2, Which Is Occasionally Targeted by Autoantibodies, Qualifies as Drug for the Treatment of Allergy, Autoimmunity, and Cancer: Collegium Internationale Allergologicum (CIA) Update 2024Al Nasar Ahmed Sehgal, Peter A Tauber, Robert B Stieger, et al.
Vaccines|July 27, 2024
Macropinocytosis Is the Principal Uptake Mechanism of Antigen-Presenting Cells for Allergen-Specific Virus-like NanoparticlesArmin Kraus, Bernhard Kratzer, Al Nasar Ahmed Sehgal, et al.
Applied Microbiology and Biotechnology|August 28, 2014
Accurate comparison of antibody expression levels by reproducible transgene targeting in engineered recombination-competent CHO cellsPatrick Mayrhofer, Bernhard Kratzer, Wolfgang Sommeregger, et al.
International Journal of Molecular Sciences|July 12, 2025
Moloney Murine Leukemia Virus-like Nanoparticles Pseudo-Typed with SARS-CoV-2 RBD for Vaccination Against COVID-19Bernhard Kratzer, Pia Gattinger, Peter A Tauber, et al.
Frontiers in Immunology|August 1, 2020
Preventive Allergen-Specific Vaccination Against Allergy: Mission Possible?Inna Tulaeva, Bernhard Kratzer, Raffaela Campana, et al.
Pageof 4